Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today ...
Tiny gene could hold key to treating malignant cardiac arrhythmia
Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.
Viral Vector And Plasmid DNA Manufacturing Market size to Show Positive Growth at a CAGR of 20.4% by 2034
The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...
Simulations show complex rainfall patterns over tropical mountains with dual peaks
A high-density rain gauge observational network in Taiwan reveals that multiple precipitation peaks exist over the ...
Surface Wave Driven Metasurfaces Open a New Era for Terahertz Optics
Researchers have developed a novel metasurface-based method to generate terahertz complex vector light fields using surface ...
News Medical on MSN12h
Breakthrough in gene therapy could help protect against heart arrhythmias
Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.
Scientists Uncover a Tiny Gene That Could End Dangerous Heart Arrhythmias
Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...
Microwaves & RF2h
PHY Solution Nears 6-Gb/s Data Rate in 5G Satcom Systems
AccelerComm’s 5G NR NTN physical-layer approach employs devices with vector-processing cores for signal processing.
Unity price target raised to $35 from $28 at Stifel
Stifel raised the firm’s price target on Unity (U) to $35 from $28 and keeps a Buy rating on the shares following Q4 results. The firm noted ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Mobile ID News1h
Zimperium Research Reveals Rising Sophistication of Mobile Phishing Attacks Targeting SMS and QR Codes
The research identifies several key factors contributing to the rise in mobile phishing attacks. Mobile devices’ smaller screen sizes make suspicious URLs more difficult to identify, while touch-based ...